Type 2 Diabetes and its Treatment with Linagliptin are both Associated with Elevated Mortality in Bullous Pemphigoid

被引：1
|
作者：
Leisti, Paivi [1 ,2 ]
Pankakoski, Anna [3 ,4 ]
Jokelainen, Jari [5 ]
Huilaja, Laura [1 ,2 ]
Panelius, Jaana [3 ,4 ]
Tasanen, Kaisa [1 ,2 ]
Varpuluoma, Outi [1 ,2 ]
机构：
[1] Oulu Univ Hosp, Med Res Ctr Oulu, Dept Dermatol, Res Unit Clin Med, Aapistie 5 A, FIN-90220 Oulu, Finland
[2] Univ Oulu, Aapistie 5 A, Oulu 90220, Finland
[3] Univ Helsinki, Dept Dermatol & Allergol, Helsinki, Finland
[4] Helsinki Univ Hosp, Helsinki, Finland
[5] Univ Oulu, Infrastruct Populat Studies, Oulu, Finland
来源：
ACTA DERMATO-VENEREOLOGICA | 2024年 / 104卷
基金：
芬兰科学院;
关键词：
D O I：
10.2340/actadv.v104.40645
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Linagliptin: An Update of Its Use in Patients with Type 2 Diabetes Mellitus
    McKeage, Kate
    DRUGS, 2014, 74 (16) : 1927 - 1946
  • [32] Linagliptin A Review of its Use in the Management of Type 2 Diabetes Mellitus
    Deeks, Emma D.
    DRUGS, 2012, 72 (13) : 1793 - 1824
  • [33] Linagliptin In Type 2 Diabetes Mellitus
    Scott, Lesley J.
    DRUGS, 2011, 71 (05) : 611 - 624
  • [34] Bullous pemphigoid and pemphigus: its incidence and mortality outcome in New Zealand
    Chung, J.
    Ramji, R.
    Coomarasamy, C.
    Patel, D.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2021, 62 (04) : E628 - E628
  • [35] Bullous pemphigoid: Its incidence, mortality and clinical outcome in New Zealand
    Chung, Jenny G.
    Ramji, Rajan
    Coomarasamy, Christin
    Jarrett, Paul
    Rademaker, Marius
    Patel, Denesh C.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2022, 63 (02) : 197 - 203
  • [36] Polymeric linagliptin nanoparticles as a sustained release treatment for type 2 diabetes
    Abbas, Ahmed
    Eissa, Noura G.
    El-Bassossy, Hany M.
    Ghorab, Mamdouh M.
    El-Nahas, Hanan M.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2024, 93
  • [37] Linagliptin for the treatment of type 2 diabetes mellitus: a drug safety evaluation
    Barnett, Anthony H.
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (01) : 149 - 159
  • [38] Pharmacology, Efficacy, and Safety of Linagliptin for the Treatment of Type 2 Diabetes Mellitus
    Neumiller, Joshua J.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (03) : 358 - 367
  • [39] Genetic Susceptibility of Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid in Chinese Patients with Type 2 Diabetes
    Shi, Mai
    Yang, Aimin
    Chow, Elaine
    Lau, Eric S.
    Tam, Claudia H.
    Ma, Ronald C.
    Cheung, Man Tung Christina
    Chan, Juliana C.
    Chan, Wai Sze Agnes
    DIABETES, 2022, 71
  • [40] Bullous pemphigoid: The role of type 2 inflammation in its pathogenesis and the prospect of targeted therapy
    Zhang, Luyao
    Chen, Zihua
    Wang, Lanting
    Luo, Xiaoqun
    FRONTIERS IN IMMUNOLOGY, 2023, 14
12345